tiprankstipranks
Trending News
More News >
Immunovant (IMVT)
NASDAQ:IMVT
US Market

Immunovant (IMVT) Balance Sheet

Compare
923 Followers

Immunovant Balance Sheet

Immunovant's total assets for Q3 2026 were $1.05B, an increase of 80.53% from the previous quarter. IMVT total liabilities were $66.26M for the fiscal quarter, a 4.75% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Assets
$ 776.22M$ 666.71M$ 405.84M$ 515.56M$ 412.49M
Total Liabilities
$ 68.78M$ 48.95M$ 43.34M$ 45.74M$ 21.01M
Total Equity Gross Minority
$ 707.45M$ 617.76M$ 362.49M$ 469.82M$ 391.48M
Other Metrics
Currency in USD

Immunovant Debt to Assets